What Researchers Did
Researchers retrospectively reviewed medical records of 29 patients diagnosed and treated for pyoderma gangrenosum at an Australian tertiary center over a decade.
What They Found
Nearly all patients received immunosuppressant therapy, with 10 (35%) undergoing surgery and 8 (28%) receiving hyperbaric oxygen therapy. Medical therapy led to complications in 23 (66%) admissions, while 21 (72%) patients showed ulcer improvement at discharge, and 80% of those receiving combined medical and surgical therapy improved or healed at 6 months.
What This Means for Canadian Patients
Canadian patients with pyoderma gangrenosum may benefit from a multidisciplinary approach combining medical and surgical therapies, given the high rate of improvement observed with this strategy. Awareness of potential complications from long-term medical treatments, such as poor blood sugar control, is crucial for managing this challenging condition.
Canadian Relevance
This study was conducted in Australia and does not have a direct Canadian connection.
Study Limitations
This retrospective study was limited by its small sample size of 29 patients and incomplete long-term follow-up data.